Hemoglobin A1c Testing Devices and Kits Market

Report Highlights

The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.

Report Includes

• 131 data tables and 46 additional tables
• An overview of the global market landscape related to the hemoglobin A1c testing devices and kits
• In-depth analysis of global market trends, featuring historical revenue data for 2020- 2022, estimated figures for 2023, as well as forecasts for 2023-2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
• Evaluation of the current market size and revenue growth prospects specific to hemoglobin A1c testing devices and kits, accompanied by a comprehensive market share analysis categorized by technology, end user, and geographical region
• Understanding of the upcoming market potential for hemoglobin A1c test devices and kits, and areas of focus to forecast this market into various segments and sub-segments
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, regulations, prospects, and contributions to the overall market
• Discussion of the role and importance of ESG in HbA1c test devices and kits market, consumer attitudes, risks and opportunity assessment, and ESG practices in the industry
• Identification of the major stakeholders and analysis of their company competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
• Detailed profiles of leading market participants including Abbott, Siemens Healthineers, Bayer AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories Inc., providing a descriptive overview of their respective businesses

Report Scope

This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.

This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.

Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.

Analyst Credentials

Partha Sarathi Das– Associate Consultant-Life Science Research
Partha Sarathi has an experience of nearly a decade in multiple domains, including healthcare, life science, biotechnology, pharmaceuticals, and healthcare IT. His expertise is in designing research studies, gathering data, and performing analysis, ultimately providing clients with actionable insights and recommendations based on their unique business needs. Designs proposal and participates in client queries for quick delivery based on their unique business needs. Academically, Parthasarathi holds a master’s degree in Biotechnology and a bachelor’s degree in Industrial Biotechnology.